Inspire Price Sales Ratio from 2010 to 2024

INSP Stock  USD 194.00  4.87  2.57%   
Inspire Medical Price Sales Ratio yearly trend continues to be relatively stable with very little volatility. Price Sales Ratio is likely to drop to 9.06. During the period from 2010 to 2024, Inspire Medical Price Sales Ratio destribution of quarterly values had range of 33.444 from its regression line and mean deviation of  11.68. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
9.54056775
Current Value
9.06
Quarterly Volatility
12.95359886
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as Interest Income of 19 M, Depreciation And Amortization of 1.7 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 9.06, Dividend Yield of 0.0 or PTB Ratio of 9.89. Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
  
Check out the analysis of Inspire Medical Correlation against competitors.

Latest Inspire Medical's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Inspire Medical Systems over the last few years. It is Inspire Medical's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inspire Medical's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Inspire Price Sales Ratio Regression Statistics

Arithmetic Mean26.86
Geometric Mean23.40
Coefficient Of Variation48.23
Mean Deviation11.68
Median26.87
Standard Deviation12.95
Sample Variance167.80
Range33.444
R-Value(0.70)
Mean Square Error91.30
R-Squared0.49
Significance0
Slope(2.04)
Total Sum of Squares2,349

Inspire Price Sales Ratio History

2024 9.06
2023 9.54
2022 17.34
2021 26.87
2020 42.5
2019 21.53
2018 12.18

About Inspire Medical Financial Statements

Inspire Medical shareholders use historical fundamental indicators, such as Price Sales Ratio, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Inspire Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Inspire Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price Sales Ratio 9.54  9.06 

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Inspire Stock

  0.62DXCM DexCom IncPairCorr
  0.59LH LaboratoryPairCorr
  0.54VREX Varex Imaging CorpPairCorr
  0.48GH Guardant HealthPairCorr
  0.43OM Outset MedicalPairCorr
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.